Lipid Panel
- UID
- IMP/IVD/2020/000048_0c0153fc7e1f2d7263416518a00c3e03_8452acff2f4af4d60dfc7c8920907f68
- Device class
- Class B
- Brand name
- NycoCard™ HbA1c
- License holder
- Abbott Diagnostics Medical Private Limited
- Approving authority
- CDSCO
- Product information
- The Afinion™ Lipid Panel is an in vitro diagnostic test for quantitative determination of total cholesterol (NycoCard™ HbA1c), high-density lipoprotein (NycoCard™ HbA1c) cholesterol and triglycerides (NycoCard™ HbA1c) in whole blood, serum and plasma
Lipid Panel is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000048_0c0153fc7e1f2d7263416518a00c3e03_8452acff2f4af4d60dfc7c8920907f68. This device is marketed under the brand name NycoCard™ HbA1c. The license holder is Abbott Diagnostics Medical Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.